← Back to Search
Novel Substrates And Inhibitors Of Peptidylglycine Alpha-amidating Monooxygenase.
A. Katopodis, S. May
Published 1990 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Peptidylglycine alpha-amidating monooxygenase (PAM, EC 184.108.40.206) catalyzes the formation of alpha-amidated peptides from their glycine-extended precursors, thus playing a key role in the processing of peptide neurohormones. We now report that PAM readily catalyzes three alternate monooxygenase reactions--sulfoxidation, amine N-dealkylation, and O-dealkylation. Thus, (4-nitrobenzyl)thioacetic acid is converted to the analogous sulfoxide, N-(4-nitrobenzyl)glycine is converted to 4-nitrobenzylamine and glyoxylate, and [(4-nitrobenzyl)oxy]acetic acid is converted to 4-nitrobenzyl alcohol and glyoxylate. All these new activities display the characteristics expected for the normal PAM-catalyzed reductive oxygenation pathway and produce an equimolar amount of glyoxylate together with the heteroatom-containing dealkylation products. The ester [(4-methoxybenzoyl)oxy]acetic acid is not a PAM substrate, but is instead a good competitive inhibitor (KI = 0.48 mM). In addition, we report that the olefinic substrate analogues trans-benzoylacrylic acid and 4-phenyl-3-butenoic acid are potent time-dependent inactivators of PAM, with inactivation exhibiting the characteristics expected for mechanism-based inhibition. Monoethyl fumarate is also a time-dependent inactivator of PAM. Finally, we introduce several small non-peptide substrates for PAM by demonstrating that PAM catalyzes the transformation of hippuric acid and several ring-substituted derivatives to the corresponding benzamides and glyoxylic acid, with the most facile substrate of this class being 4-nitrohippuric acid. These compounds are the smallest amide substrates yet reported for PAM, and it is thus apparent that only the minimal structure of an acylglycine is required for PAM-catalyzed oxygenative amidation.
This paper references
Tissue distribution and characterization of peptide C-terminal α-amidating activity in rat
J. Sakata (1986)
Chiral sulfoxidations catalyzed by rat liver cytochromes P-450.
D. Waxman (1982)
Dopamine beta-hydroxylase. Comparative specificities and mechanisms of the oxygenation reactions.
S. May (1981)
Dopamine beta-hydroxylase of adrenal chromaffin granules: structure and function.
L. C. Stewart (1988)
New oxyfunctionalization capabilities for .omega.-hydroxylases. Asymmetric aliphatic sulfoxidation and branched ether demethylation
A. Katopodis (1988)
Electron transfer from nitrogen in microsomal oxidation of amine and amide. Simulation of microsomal oxidation by anodic oxidation
T. Shono (1982)
Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
S. Padgette (1985)
Dopamine beta-hydroxylase. Demonstration of enzymatic ketonization of the product enantiomer S-octopamine.
S. May (1981)
Cloning of cDNA encoding a new peptide C-terminal α-amidating enzyme having a putative membrane-spanning domain from Xenopuslaevis skin
K. Ohsuye (1988)
B. Eipper (1988)
Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene.
S. May (1983)
Peptide C-terminal α-amidating enzyme purified to homogeneity from Xenopuslaevis skin
Kazuhiko Mizuno (1986)
MNDO calculation of kinetic isotope effects in model cytochrome P-450 oxidations
J.Paul Shea (1983)
Asymmetric sulfoxidation by dopamine .beta.-hydroxylase, an oxygenase heretofore considered specific for methylene hydroxylation
S. May (1980)
Purification and characterization of a peptidyl glycine monooxygenase from porcine pituitary.
J. S. Kizer (1986)
Enzyme‐catalysed peptide amidation
A. Bradbury (1987)
Kinetic study on enzymatic s-oxygenation promoted by a reconstituted system with purified cytochrome P-450
Y. Watanabe (1980)
Dopamine .beta.-monooxygenase-catalyzed aromatization of 1-(2-aminoethyl)-1,4-cyclohexadiene: redirection of specificity and evidence for a hydrogen-atom-transfer mechanism
K. Wimalasena (1989)
Biosynthesis of the C-terminal amide in peptide hormones
A. Bradbury (1987)
143. Studies in peroxidase action. Part II. The oxidation of p-toluidine
B. Saunders (1940)
Formation of peptide amides by peptidylglycine .alpha.-amidating monooxygenase: a new assay and stereochemistry of hydrogen loss
S. E. Ramer (1988)
Purification and characterization of peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary.
A. Murthy (1986)
CYTOCHROME P-450 CATALYZED OXIDATION OF QUADRICYCLANE. EVIDENCE FOR A RADICAL CATION INTERMEDIATE
R. Stearns (1985)
Mechanism of C-terminal amide formation by pituitary enzymes
A. Bradbury (1982)
A new facile trinitrophenylated substrate for peptide alpha-amidation and its use to characterize PAM activity in chromaffin granules.
A. Katopodis (1988)
Studies on the chirality of sulfoxidation catalyzed by bacterial flavoenzyme cyclohexanone monooxygenase and hog liver flavin adenine dinucleotide containing monooxygenase.
D. Light (1982)
Ruthenium(II) tris(bipyrazyl) dication: a new photocatalyst
R. Crutchley (1980)
The catalytic mechanism of cytochrome P-450. Spin-trapping evidence for one-electron substrate oxidation.
O. Augusto (1982)
Bioactivation of Catha edulis alkaloids: enzymatic ketonization of norpseudoephedrine.
S. May (1982)
Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation.
P. R. Ortiz de Montellano (1982)
Kinetic isotope effects on cytochrome P-450-catalyzed oxidation reactions. The oxidative O-dealkylation of 7-ethoxycoumarin.
G. Miwa (1984)
Ascorbate depletion as a consequence of product recycling during dopamine beta-monooxygenase catalyzed selenoxidation.
S. May (1987)
The amidating enzyme in pituitary will accept a peptide with C-terminal D-alanine as substrate.
A. E. Landymore-Lim (1983)
Chemical mechanisms of catalysis by cytochromes P-450: a unified view
F. Guengerich (1984)
Facile synthesis of amino acid and peptide esters under mild conditions via cesium salts.
Wang S-S (1977)
Facile stereoselective allylic hydroxylation by dopamine .beta.-monooxygenase
S. Sirimanne (1988)
The allantoin content of blood.
A. Christman (1944)
Mechanistic studies on dopamine .beta.-monooxygenase catalysis: N-dealkylation and mechanism-based inhibition by benzylic-nitrogen-containing compounds. Evidence for a single-electron-transfer mechanism
K. Wimalasena (1987)
Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid.
B. Eipper (1983)
Enzymatic Oxidation of Alkyl Sulfides by Cytochrome P-450 and Hydroxyl Radical
Y. Watanabe (1981)
Enzymatic peptidyl .alpha.-amidation proceeds through formation of an .alpha.-hydroxyglycine intermediate
S. D. Young (1989)
Mechanism-based inhibitors of dopamine β-hydroxylase
P. Fitzpatrick (1987)
Mechanisms of enzymatic S-oxygenation of thioanisole derivatives and O-demethylation of anisole derivatives promoted by both microsomes and a reconstituted system with purified cytochrome P-450.
Y. Watanabe (1982)
The formation and metabolism of N-hydroxymethyl compounds. Part 8. The oxidative decarboxylation of N-aroylglycines to N-(acetoxymethyl)benzamides and N-formylbenzamides with lead(IV) acetate
A. P. Gledhill (1986)
Purification of a peptidylglycine alpha-amidating enzyme from transplantable rat medullary thyroid carcinomas.
N. M. Mehta (1988)
Structure of the precursor to an enzyme mediating COOH-terminal amidation in peptide biosynthesis.
B. Eipper (1987)
This paper is referenced by
Role for an Essential Tyrosine in Peptide Amidation*
M. De (2006)
Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.
N. Iwai (1999)
Amidative peptide processing and vascular function.
C. D. Oldham (1997)
Amidation of bioactive peptides: the structure of peptidylglycine alpha-hydroxylating monooxygenase.
S. Prigge (1997)
Substrate-mediated electron transfer in peptidylglycine α-hydroxylating monooxygenase
S. Prigge (1999)
Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme.
A. Kolhekar (1997)
In vivo inhibition of peptidylglycine-alpha-hydroxylating monooxygenase by 4-phenyl-3-butenoic acid.
G. Mueller (1999)
Design, synthesis, kinetic analysis, molecular modeling, and pharmacological evaluation of novel inhibitors of peptide amidation
M. Foster (2008)
The secretory-vesicle ascorbate-regenerating system: a chain of concerted H+/e(-)-transfer reactions.
D. Njus (1993)
Peptidyl‐α‐Hydroxyglycine α‐Amidating Lyase (PAL)
E. Chufán (2010)
The evaluation of novel anti-inflammatory compounds in cell culture and experimental arthritis and identification of an inhibitor to early-stage loblolly pine somatic embryo growth
Jacob Lucrezi (2013)
Peptide amidation in an invertebrate: purification, characterization, and inhibition of peptidylglycine alpha-hydroxylating monooxygenase from the heads of honeybees (Apis mellifera).
T. Zabriskie (1994)
Oxygen insertion in organic substrates catalyzed by copper compounds
E. Spodine (1992)
Kinetic analyses of peptidylglycine α-amidating monooxygenase from pancreatic islets
B. D. Noe (1991)
Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency.
K. M. Morris (2012)
Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic properties
A. Ali (2015)
A pathway for the biosynthesis of fatty acid amides.
K. Merkler (1999)
A novel enzyme from bovine neurointermediate pituitary catalyzes dealkylation of alpha-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine alpha-amidating monooxygenase in peptide amidation.
A. Katopodis (1990)
Dioxygen Reactivity in Copper Proteins and Complexes
S. Fox (1995)
Type 2 Diabetes Risk Alleles Reveal a Role for Peptidylglycine Alpha-amidating Monooxygenase in Beta Cell Function Running title : Effects of PAM on beta cell function
Anne Raimondo (2017)
Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme.
E. Chufán (2009)
Unsaturated thioacetic acids as novel mechanism-based inhibitors of peptidylglycine α-hydroxylating monooxygenase
P. Casara (1996)
Differential regulation of peptide alpha-amidation by dexamethasone and disulfiram.
W. Driscoll (1999)
The enzymatic formation of novel bile acid primary amides.
L. King (2000)
The Enzymology of Peptide Amidation
D. J. Merkler (1993)
Probing the Peptidylglycine α‐Hydroxylating Monooxygenase Active Site with Novel 4‐Phenyl‐3‐butenoic Acid Based Inhibitors
E. Langella (2010)
Pharmacological evaluation of 1-(carboxymethyl)-3,5-diphenyl-2-methylbenzene, a novel arylacetic acid with potential anti-inflammatory properties
S. J. Cutler (1998)
Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
C. Hiley (2007)
Steady State and Theoretical Investigations of Peptidylglycine α-Amidating Monooxygenase (PAM)
Edward W. Lowe (2008)
Absence of an Essential Thiol in Human Glutaminyl Cyclase: Implications for Mechanism
Jeffrey S. Temple (1998)
A new proposal for the mechanism of glycine hydroxylation as catalyzed by peptidylglycine alpha-hydroxylating monooxygenase (PHM).
T. C. Owen (2004)
Functional and structural characterization of peptidylamidoglycolate lyase, the enzyme catalyzing the second step in peptide amidation.
A. Katopodis (1991)See more